{
    "clinical_study": {
        "@rank": "37046", 
        "brief_summary": {
            "textblock": "OBJECTIVES:\n\n      Assess the efficacy of a single infusion of a high titer pertussis immune globulin for the\n      treatment of severe pertussis in children."
        }, 
        "brief_title": "Intravenous Pertussis Immune Globulin in Patients With Severe Childhood Pertussis Infection", 
        "condition": [
            "Pertussis", 
            "Whooping Cough"
        ], 
        "condition_browse": {
            "mesh_term": "Whooping Cough"
        }, 
        "detailed_description": {
            "textblock": "PROTOCOL OUTLINE: This is a randomized, multicenter study. Patients are randomized to\n      receive an infusion of either pertussis immune globulin or placebo (0.9% saline).\n\n      Patients are followed every 2 weeks for up to 6 months."
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "-  Documented infection with Bordetella pertussis"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "5 Years", 
            "minimum_age": "N/A"
        }, 
        "enrollment": "174", 
        "firstreceived_date": "October 18, 1999", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT00004422", 
            "org_study_id": "199/13322", 
            "secondary_id": [
                "IWK-FDR001044", 
                "P9701"
            ]
        }, 
        "intervention": {
            "intervention_name": "immune globulin", 
            "intervention_type": "Drug"
        }, 
        "intervention_browse": {
            "mesh_term": [
                "Antibodies", 
                "Immunoglobulins"
            ]
        }, 
        "keyword": [
            "bacterial infection", 
            "immunologic disorders and infectious disorders", 
            "pertussis", 
            "rare disease"
        ], 
        "lastchanged_date": "June 23, 2005", 
        "overall_official": {
            "affiliation": "IWK Health Centre", 
            "last_name": "Scott A. Halperin", 
            "role": "Study Chair"
        }, 
        "overall_status": "Active, not recruiting", 
        "oversight_info": {
            "authority": "United States: Federal Government"
        }, 
        "phase": "Phase 3", 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT00004422"
        }, 
        "source": "FDA Office of Orphan Products Development", 
        "sponsors": {
            "collaborator": {
                "agency": "IWK Health Centre", 
                "agency_class": "Other"
            }, 
            "lead_sponsor": {
                "agency": "FDA Office of Orphan Products Development", 
                "agency_class": "U.S. Fed"
            }
        }, 
        "start_date": "August 1997", 
        "study_design": "Allocation: Randomized, Primary Purpose: Treatment", 
        "study_type": "Interventional", 
        "verification_date": "June 2000"
    }, 
    "geocoordinates": {}
}